EGT022, an RGD-containing recombinant disintegrin, targets integrin β3 in endothelial cells to inhibit VEGF-induced angiogenic process, providing a potential treatment for VEGF-induced neovascularization in the retina
被引:0
|
作者:
Kim, Seok-Hyun
论文数: 0引用数: 0
h-index: 0
机构:
EyeGene Inc, R&D Ctr, Goyang, Gyunggi, South KoreaEyeGene Inc, R&D Ctr, Goyang, Gyunggi, South Korea
Kim, Seok-Hyun
[1
]
机构:
[1] EyeGene Inc, R&D Ctr, Goyang, Gyunggi, South Korea